BMC Dermatology

(ISSN: 1471-5945)

This journal no longer participates in Medscape Publishers' Circle Program. No new articles will be republished.

Subscribe Submit

Articles Available on Medscape

 
 

BMC Dermatology's Latest Table of Contents

2016 - 16 (1)

  • Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort). 
  • A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis. 
  • Effect of 12-O-tetradecanoylphorbol-13-acetate-induced psoriasis-like skin lesions on systemic inflammation and atherosclerosis in hypercholesterolaemic apolipoprotein E deficient mice. 
  • The first Danish family reported with an AQP5 mutation presenting diffuse non-epidermolytic palmoplantar keratoderma of Bothnian type, hyperhidrosis and frequent Corynebacterium infections: a case report. 
  • Nipple adenoma in a female patient presenting with persistent erythema of the right nipple skin: case report, review of the literature, clinical implications, and relevancy to health care providers who evaluate and treat patients with dermatologic conditions of the breast skin. 
 
 
Member of Medscape Publishers’ Circle®

Mission Statement: BMC Dermatology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of skin disorders, as well as related molecular genetics, pathophysiology, and epidemiology.

Member of Medscape Publishers’ Circle®